Cargando…

Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion

SIMPLE SUMMARY: Barth syndrome (BTHS) is a disease that affects energy production. It results from mutations on the X chromosome, and thus it mainly affects males since they have only one copy (females have two X chromosomes). Although BTHS is rare, the consequences can be severe. BTHS affects the h...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomczewski, Michelle V., Chan, John Z., Al-Majmaie, Duaa M., Liu, Ming Rong, Cocco, Alex D., Stark, Ken D., Strathdee, Douglas, Duncan, Robin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525480/
https://www.ncbi.nlm.nih.gov/pubmed/37759637
http://dx.doi.org/10.3390/biology12091238
_version_ 1785110794321526784
author Tomczewski, Michelle V.
Chan, John Z.
Al-Majmaie, Duaa M.
Liu, Ming Rong
Cocco, Alex D.
Stark, Ken D.
Strathdee, Douglas
Duncan, Robin E.
author_facet Tomczewski, Michelle V.
Chan, John Z.
Al-Majmaie, Duaa M.
Liu, Ming Rong
Cocco, Alex D.
Stark, Ken D.
Strathdee, Douglas
Duncan, Robin E.
author_sort Tomczewski, Michelle V.
collection PubMed
description SIMPLE SUMMARY: Barth syndrome (BTHS) is a disease that affects energy production. It results from mutations on the X chromosome, and thus it mainly affects males since they have only one copy (females have two X chromosomes). Although BTHS is rare, the consequences can be severe. BTHS affects the heart, immune system, and muscles, so boys and men with BTHS are at a high risk of heart attacks and death from infections, and they tire easily, which impacts quality of life. Women with one mutated X chromosome are typically thought to be asymptomatic, so they have not been studied very much. However, in other diseases caused by X chromosome mutations, females that were thought to be healthy developed symptoms after they got older. In this work, we studied female mice with one mutated X chromosome, which are models of female carriers of BTHS. We found that with advancing age, the carriers have some slowdown in their running speed, which is like that seen in male mice but less severe. They also weigh less and are better able to maintain their blood sugar, which could be beneficial. Our work shows that female carriers can have symptoms and supports further research in women. ABSTRACT: Barth syndrome (BTHS) is caused by mutations in tafazzin resulting in deficits in cardiolipin remodeling that alter major metabolic processes. The tafazzin gene is encoded on the X chromosome, and therefore BTHS primarily affects males. Female carriers are typically considered asymptomatic, but age-related changes have been reported in female carriers of other X-linked disorders. Therefore, we examined the phenotype of female mice heterozygous for deletion of the tafazzin gene (Taz-HET) at 3 and 12 months of age. Food intakes, body masses, lean tissue and adipose depot weights, daily activity levels, metabolic measures, and exercise capacity were assessed. Age-related changes in mice resulted in small but significant genotype-specific differences in Taz-HET mice compared with their female Wt littermates. By 12 months, Taz-HET mice weighed less than Wt controls and had smaller gonadal, retroperitoneal, and brown adipose depots and liver and brain masses, despite similar food consumption. Daily movement, respiratory exchange ratio, and total energy expenditure did not vary significantly between the age-matched genotypes. Taz-HET mice displayed improved glucose tolerance and insulin sensitivity at 12 months compared with their Wt littermates but had evidence of slightly reduced exercise capacity. Tafazzin mRNA levels were significantly reduced in the cardiac muscle of 12-month-old Taz-HET mice, which was associated with minor but significant alterations in the heart cardiolipin profile. This work is the first to report the characterization of a model of female carriers of heterozygous tafazzin deficiency and suggests that additional study, particularly with advancing age, is warranted.
format Online
Article
Text
id pubmed-10525480
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105254802023-09-28 Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion Tomczewski, Michelle V. Chan, John Z. Al-Majmaie, Duaa M. Liu, Ming Rong Cocco, Alex D. Stark, Ken D. Strathdee, Douglas Duncan, Robin E. Biology (Basel) Article SIMPLE SUMMARY: Barth syndrome (BTHS) is a disease that affects energy production. It results from mutations on the X chromosome, and thus it mainly affects males since they have only one copy (females have two X chromosomes). Although BTHS is rare, the consequences can be severe. BTHS affects the heart, immune system, and muscles, so boys and men with BTHS are at a high risk of heart attacks and death from infections, and they tire easily, which impacts quality of life. Women with one mutated X chromosome are typically thought to be asymptomatic, so they have not been studied very much. However, in other diseases caused by X chromosome mutations, females that were thought to be healthy developed symptoms after they got older. In this work, we studied female mice with one mutated X chromosome, which are models of female carriers of BTHS. We found that with advancing age, the carriers have some slowdown in their running speed, which is like that seen in male mice but less severe. They also weigh less and are better able to maintain their blood sugar, which could be beneficial. Our work shows that female carriers can have symptoms and supports further research in women. ABSTRACT: Barth syndrome (BTHS) is caused by mutations in tafazzin resulting in deficits in cardiolipin remodeling that alter major metabolic processes. The tafazzin gene is encoded on the X chromosome, and therefore BTHS primarily affects males. Female carriers are typically considered asymptomatic, but age-related changes have been reported in female carriers of other X-linked disorders. Therefore, we examined the phenotype of female mice heterozygous for deletion of the tafazzin gene (Taz-HET) at 3 and 12 months of age. Food intakes, body masses, lean tissue and adipose depot weights, daily activity levels, metabolic measures, and exercise capacity were assessed. Age-related changes in mice resulted in small but significant genotype-specific differences in Taz-HET mice compared with their female Wt littermates. By 12 months, Taz-HET mice weighed less than Wt controls and had smaller gonadal, retroperitoneal, and brown adipose depots and liver and brain masses, despite similar food consumption. Daily movement, respiratory exchange ratio, and total energy expenditure did not vary significantly between the age-matched genotypes. Taz-HET mice displayed improved glucose tolerance and insulin sensitivity at 12 months compared with their Wt littermates but had evidence of slightly reduced exercise capacity. Tafazzin mRNA levels were significantly reduced in the cardiac muscle of 12-month-old Taz-HET mice, which was associated with minor but significant alterations in the heart cardiolipin profile. This work is the first to report the characterization of a model of female carriers of heterozygous tafazzin deficiency and suggests that additional study, particularly with advancing age, is warranted. MDPI 2023-09-14 /pmc/articles/PMC10525480/ /pubmed/37759637 http://dx.doi.org/10.3390/biology12091238 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tomczewski, Michelle V.
Chan, John Z.
Al-Majmaie, Duaa M.
Liu, Ming Rong
Cocco, Alex D.
Stark, Ken D.
Strathdee, Douglas
Duncan, Robin E.
Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion
title Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion
title_full Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion
title_fullStr Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion
title_full_unstemmed Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion
title_short Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion
title_sort phenotypic characterization of female carrier mice heterozygous for tafazzin deletion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525480/
https://www.ncbi.nlm.nih.gov/pubmed/37759637
http://dx.doi.org/10.3390/biology12091238
work_keys_str_mv AT tomczewskimichellev phenotypiccharacterizationoffemalecarriermiceheterozygousfortafazzindeletion
AT chanjohnz phenotypiccharacterizationoffemalecarriermiceheterozygousfortafazzindeletion
AT almajmaieduaam phenotypiccharacterizationoffemalecarriermiceheterozygousfortafazzindeletion
AT liumingrong phenotypiccharacterizationoffemalecarriermiceheterozygousfortafazzindeletion
AT coccoalexd phenotypiccharacterizationoffemalecarriermiceheterozygousfortafazzindeletion
AT starkkend phenotypiccharacterizationoffemalecarriermiceheterozygousfortafazzindeletion
AT strathdeedouglas phenotypiccharacterizationoffemalecarriermiceheterozygousfortafazzindeletion
AT duncanrobine phenotypiccharacterizationoffemalecarriermiceheterozygousfortafazzindeletion